Antiretroviral therapy alone

Juan A. Arnaiz · FDA-approved active Small molecule Quality 5/100

Antiretroviral therapy alone is a Small molecule drug developed by Juan A. Arnaiz. It is currently FDA-approved. Also known as: stavudine, Lamivudine, Indinavir.

Antiretroviral therapy (ART) is used to treat HIV/AIDS, as indicated by ClinicalTrials.gov. The specific combination of drugs, DTG/3TC, is also studied in relation to ART, as per ClinicalTrials.gov.

At a glance

Generic name	Antiretroviral therapy alone
Also known as	stavudine, Lamivudine, Indinavir
Sponsor	Juan A. Arnaiz
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India (NA)
• Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (PHASE3)
• The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY (NA)
• REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE: A Multi-Center, Single-Arm, Open-Label, Phase 4 Study Assessing the Safety and Efficacy of B/F/TAF in HIV-Positive Adults Returning to Care After Experiencing a Treatment Interruption of ≥12 Weeks (PHASE4)
• A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
• Getting to Zero Among HHI MSM in the American South (NA)
• Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn
• Study of GS-3242 in Participants With HIV-1; Substudy-05 (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Antiretroviral therapy alone CI brief — competitive landscape report
• Antiretroviral therapy alone updates RSS · CI watch RSS
• Juan A. Arnaiz portfolio CI

Frequently asked questions about Antiretroviral therapy alone

What is Antiretroviral therapy alone?

Antiretroviral therapy alone is a Small molecule drug developed by Juan A. Arnaiz.

Who makes Antiretroviral therapy alone?

Antiretroviral therapy alone is developed and marketed by Juan A. Arnaiz (see full Juan A. Arnaiz pipeline at /company/juan-a-arnaiz).

Is Antiretroviral therapy alone also known as anything else?

Antiretroviral therapy alone is also known as stavudine, Lamivudine, Indinavir.

What development phase is Antiretroviral therapy alone in?

Antiretroviral therapy alone is FDA-approved (marketed).

Related

• Manufacturer: Juan A. Arnaiz — full pipeline
• Also known as: stavudine, Lamivudine, Indinavir